v3.26.1
Liabilities Related to Sale of Commissions Receivable (Additional Information) (Details)
Jun. 30, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Company''s estimated effective annual interest rate 8.87% 8.31%